Changmao Biochemical Engineering Company Limited

HKEX:0954.HK

0.46 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 637.078730.034547.976444.106494.58639.12630.841594.402514.779561.669703.032653.218620.233515.574385.302418.426397.42321.4493.04295.22889.321
Cost of Revenue 611.269549.203509.296341.065359.425509.394555.846488.87399.949450.34534.023525.765506.045378.212295.961328.423319.555217.22816.63117.02212.344
Gross Profit 25.809180.83138.68103.041135.155129.72674.995105.532114.83111.329169.009127.453114.188137.36289.34190.00377.865104.21276.41178.20676.977
Gross Profit Ratio 0.0410.2480.0710.2320.2730.2030.1190.1780.2230.1980.240.1950.1840.2660.2320.2150.1960.3240.8210.8210.862
Reseach & Development Expenses 10.20913.9212.64911.59110.3028.6778.1178.0367.538.48516.00513.674000000000
General & Administrative Expenses 74.61888.54573.48670.88860.96163.55462.21161.95659.61558.96569.10961.35552.39549.32538.9726.03923.26423.884000
Selling & Marketing Expenses 8.6898.4218.2113.93214.06415.16918.46417.9615.09614.19615.34816.24712.73110.0288.1277.6447.1057.015000
SG&A 83.30796.96681.69684.8275.02578.72380.67579.91674.71173.16184.45777.60265.12659.35347.09733.68330.36930.899000
Other Expenses 0-3.477-4.664-2.853-3.7462.3572.4231.3621.1550.8830.2070.474-5.4-5.02-10.778-1.792-2.779-4.76633.3222.43538.645
Operating Expenses 76.56293.48977.03281.96771.27976.00967.89176.7871.64666.21882.66972.56859.72654.33336.31931.89127.5926.13333.3222.43538.645
Operating Income -52.04889.373-38.35216.99962.8155.4541.21534.43750.3245.06788.56169.0654.46283.02953.02258.11250.38479.68744.42657.13841.805
Operating Income Ratio -0.0820.122-0.070.0380.1270.0870.0020.0580.0980.080.1260.1060.0880.1610.1380.1390.1270.2480.4770.60.468
Total Other Income Expenses Net -80.193-1.729122.7610.153-0.257-0.853-3.0880.3640.687-3.152-6.958-9.735-8.013.965-3.081-9.065-9.688-5.342-3.243-3.319-2.744
Income Before Tax -58.5887.64484.40917.15262.55354.6011.24434.80151.00741.91581.60359.32546.45286.99449.94149.04740.69674.34541.18453.8239.061
Income Before Tax Ratio -0.0920.120.1540.0390.1260.0850.0020.0590.0990.0750.1160.0910.0750.1690.130.1170.1020.2310.4430.5650.437
Income Tax Expense 27.9386.28626.2020.4094.6264.692-1.4561.4855.8614.49711.2759.7574.74911.1357.0743.4136.0786.9876.217.2943.634
Net Income -86.05781.42358.31816.82758.29950.5253.38233.17245.27437.22369.99249.45541.10575.77343.20345.92934.64867.35834.97346.52535.427
Net Income Ratio -0.1350.1120.1060.0380.1180.0790.0050.0560.0880.0660.10.0760.0660.1470.1120.110.0870.210.3760.4890.397
EPS -0.160.150.110.0320.110.0950.0060.0630.0850.070.130.0930.0780.120.060.0670.0510.0990.10.140.27
EPS Diluted -0.160.150.110.0320.110.0950.0060.0630.0850.070.130.0930.0780.120.060.0670.0510.0990.10.140.27
EBITDA -7.203128.254-10.29250.146100.53490.19942.23869.34286.66381.598120.33593.75487.531112.84480.03382.29867.86391.60945.98258.47841
EBITDA Ratio -0.0110.176-0.0190.1130.2030.1410.0670.1170.1680.1450.1710.1440.1410.2190.2080.1970.1710.2850.4940.6140.459